Search News

Corporate Industry Technology Medical Updates

ECMO

Medical Updates
Big country Great Medic｜Nianguo Dong's team, pioneer of heart transplantation in China 2021-06-09
Corporate
From China to the Global Stage: magAssist Selected Among Fortune’s 23 Featured Healthcare Companies 2025-11-15
Medical Updates
"Spiral Escalation–De-escalation" Therapy for End-stage Heart Failure Recognized as a Major Clinical Technology in Guangzhou 2025-10-25
Industry
Showcasing magAssist's Extracorporeal Support Solutions at 36th Annual ELSO Conference 2025-09-30
Corporate
magAssist Recognized as a 2025 Potential Unicorn Enterprise in Jiangsu 2025-09-30
Industry
Academic Symposium at Zhujiang Hospital Highlights Advances in Heart Failure Treatment with Extracorporeal VAD 2025-08-15
Corporate
magAssist Shortlisted for 2025 Prix Galien USA Best Start-Up Award 2025-08-14
Medical Updates
Zhujiang Hospital Transitions from ECMO + IABP to MoyoAssist® in the Management of Cardiogenic Shock 2025-04-30
Corporate
magAssist was included in the catalogue of "Advantageous Enterprises in the Fourth Batch of Intellectual Property Strong Companies Cultivation Project in Suzhou City". 2024-12-20
Corporate
magAssist ECMO approved in the Transformation of Scientific and Technological Achievements Special Fund 2023-08-28

Tabs： pVAD, cardiogenic shock, external life support systems, ECMO devices, IABP, Bridge-to-recovery, cardiogenic shock treatment, MoyoAssist Extra-VAD, solid technology of artificial hearts, Awards,